Carl G. Colin

Array ( [id] => 10529134 [patent_doc_number] => 09255263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Antithrombotic compounds' [patent_app_type] => utility [patent_app_number] => 13/394177 [patent_app_country] => US [patent_app_date] => 2010-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 10129 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406440 [patent_doc_number] => 20120238509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'UROCORTIN 2 ANALOGS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/392828 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12916 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290359 [patent_doc_number] => 20120178690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'NOVEL NETRIN DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/377418 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19510 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355322 [patent_doc_number] => 08673855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Phosphatidylinositol 3-kinases activity regulator including the fifth zinc finger domain of FOG2' [patent_app_type] => utility [patent_app_number] => 13/703006 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9187 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817164 [patent_doc_number] => 08926946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Peptides for transport of therapeutics and their carriers in mouse models and humans' [patent_app_type] => utility [patent_app_number] => 13/376362 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14305 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406423 [patent_doc_number] => 20120238491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'IMMUNOLOGICALLY ACTIVE LIPOPEPTIDES AND METHODS FOR USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/263755 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6857 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160144 [patent_doc_number] => 20120101046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR RETINAL DISEASE AND METHOD FOR PROPHYLAXIS OR THERAPY OF RETINAL DISEASE USING JNK (C-JUN AMINO-TERMINAL KINASE) - INHIBITORY PEPTIDE, AND USE OF THE PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/260231 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7652 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101046.pdf [firstpage_image] =>[orig_patent_app_number] => 13260231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815138 [patent_doc_number] => 20130116183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'PEPTIDES THAT INHIBIT ANGIOTENSIN CONVERTING ENZYME AND PEPTIDES WITH ANTIOXIDANT ACTIVITY PURIFIED FROM OVOTRANSFERRIN AND METHODS OF PRODUCING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/256839 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10508 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138345 [patent_doc_number] => 20120093723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'NANOCARRIER COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/255635 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12851 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093723.pdf [firstpage_image] =>[orig_patent_app_number] => 13255635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417586 [patent_doc_number] => 20120245086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'WNT10-Derived Peptide and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/393370 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501461 [patent_doc_number] => 20110263489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMBINATION THERAPY TO COMBAT HELMINTH RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/126709 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 19497 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263489.pdf [firstpage_image] =>[orig_patent_app_number] => 13126709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657270 [patent_doc_number] => 20110306539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'PROCESS FOR MAKING PARTICLES FOR DELIVERY OF DRUG NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 13/120146 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27122 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306539.pdf [firstpage_image] =>[orig_patent_app_number] => 13120146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973598 [patent_doc_number] => 20110152507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PROCESSES FOR REFOLDING OF INSULIN' [patent_app_type] => utility [patent_app_number] => 12/990352 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7274 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152507.pdf [firstpage_image] =>[orig_patent_app_number] => 12990352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055661 [patent_doc_number] => 20110112021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/990101 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26494 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112021.pdf [firstpage_image] =>[orig_patent_app_number] => 12990101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149836 [patent_doc_number] => 20110021431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Methods And Compositions For Medical Articles Produced From Proteinaceous Compounds' [patent_app_type] => utility [patent_app_number] => 12/934705 [patent_app_country] => US [patent_app_date] => 2009-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9704 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021431.pdf [firstpage_image] =>[orig_patent_app_number] => 12934705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6061991 [patent_doc_number] => 20110200527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Peptide Ligand Directed Drug Delivery' [patent_app_type] => utility [patent_app_number] => 12/741348 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11789 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200527.pdf [firstpage_image] =>[orig_patent_app_number] => 12741348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107661 [patent_doc_number] => 20070066539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof' [patent_app_type] => utility [patent_app_number] => 10/571026 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8871 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066539.pdf [firstpage_image] =>[orig_patent_app_number] => 10571026 [rel_patent_id] =>[rel_patent_doc_number] =>)